Webcast of Presentation by Elekta's CEO Tomas Puusepp on February 6

Webcast of Presentation by Elekta's CEO Tomas Puusepp on February 6

Stockholm Sweden — Monday, February 4, 2008

On February 6, Tomas Puusepp, President & CEO of Elekta will present at Merrill Lynch Global Pharmaceuticals, Biotechnology & Medical Devices Conference in New York.

The presentation by Mr Puusepp will be held at 9.20-10.00am ET (15.20-16.00 CET) and an audio only live webcast of the presentation and Q&A session will be available on:

http://www.veracast.com/webcasts/ml/globalpharma08/45203401.cfm

This link will be live just prior to the start of the presentation and will be available for on-demand replay within 24 hours.

Please note:
To access the webcast presentation, you will need Windows Media Player and/or Real Player installed on your computer. This event requires that you register prior to accessing any of the webcasts and requires that you have 'cookies' enabled on your browser.

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

Visit Elekta - www.elekta.com

Press Releases

For further information, please contact

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Email: stina.thorman@elekta.com
Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.lee@elekta.com
Time zone: EDT: Eastern Daylight Time